Real-world glycemic outcomes in patients with type 2 diabetes initiating exenatide once weekly and liraglutide once daily: a retrospective cohort study
William B Saunders,1 Hiep Nguyen,2 Iftekhar Kalsekar2 1Department of Public Health Sciences, College of Health and Human Services, The University of North Carolina at Charlotte, Charlotte, NC, 2AstraZeneca, Fort Washington, PA, USA Aim: The glucagon-like peptide-1 receptor agonists exenatide once we...
Saved in:
Main Authors: | Saunders WB, Nguyen H, Kalsekar I |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2016
|
Subjects: | |
Online Access: | https://doaj.org/article/2823c33f51e4422c94a92ae44de99a39 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Critical appraisal of once-weekly formulation of exenatide in the control of type 2 diabetes mellitus
by: Seewoodhary J, et al.
Published: (2010) -
Exenatide once weekly: sustained improvement in glycemic control and cardiometabolic measures through 3 years
by: MacConell L, et al.
Published: (2013) -
Emerging utility of once-weekly exenatide in patients with type 2 diabetes
by: Goud A, et al.
Published: (2015) -
Exenatide extended-release: a once weekly treatment for patients with type 2 diabetes
by: Mann KV, et al.
Published: (2014) -
Critical appraisal of once-weekly formulation of exenatide in the control of type 2 diabetes mellitus
by: Jason Seewoodhary, et al.
Published: (2010)